← Back to Patent Explorer
US4046722A Expired / Lapsed US ⏱️ 0.0 years remaining

Immunological materials

Assignee: GD Searle and Co Ltd
•
Filing: 1976-01-14
•
Granted: 1977-09-06
•
Expires: 1996-01-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention is concerned with a cytotoxic agent comprising an immunoglobulin specific for antigens on the surface of the cell to be killed having 1-10 polymer carrier molecules covalently bonded thereto and the polymer carrier having 5-500 molecules of a cytotoxic drug covalently bound. The compounds of the present invention are useful as anti tumor agents.

Inventors

  • 👤 George Ferdinand Rowland

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 06:39
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/395; A61K39/44; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/59; A61K47/61; A61K47/62; A61K47/64; A61K47/645; A61K47/68; A61K47/6835; A61K47/6883; A61K47/6889; C; C07; C07C; C07C271/00; C07C271/06; C07C271/08; C07C271/10; C07C271/22; Y; Y10; Y10S; Y10S530/00; Y10S530/806

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 72 words
A cytotoxic agent comprising an immunoglobulin specific for antigens on the surface of cells to be killed having 1-10 polymer carrier molecules convalently bound thereto, said polymer carrier having about 5-500 molecules of a cytotoxic drug covalently bound thereto and said polymer carrier having a molecular weight of 5000-500,000 and free carboxyl, amino or cycloimidocarbonate groups for covalently bonding, said cytotoxic drug also having amino or carboxyl groups available for covalent bonding.
Claim 2
Dependent Claim 72 words
A cytotoxic agent comprising an immunoglobulin specific for antigens on the surface of cells to be killed having 1-10 polymer carrier molecules convalently bound thereto, said polymer carrier having about 5-500 molecules of a cytotoxic drug covalently bound thereto and said polymer carrier having a molecular weight of 5000-500,000 and free carboxyl, amino or cycloimidocarbonate groups for covalently bonding, said cytotoxic drug also having amino or carboxyl groups available for covalent bonding.
Claim 3
Dependent Claim 180 words
A cyctotoxic agent according to claim 1 represented by the formula ##STR43## wherein Ig represents an immunoglobulin specific to antigens on the surface of cells to be killed; the polymer carrier has a molecular weight of 5000-500,000 and is selected from the group of polymers comprising: a. dextran activated with cyanogen bromide to form cycloimidocarbonate and functionalized with --NH(CH 2 ) x CO 2 H, --NH--(CH 2 ) x --NH 2 , wherein x is 3-8, b. aminoethylated dextran, c. polyglutamic acid, d. polyaspartic acid, e. polyarginine, f. serum albumen, g. fibrinogen, h. γ-globulin, h. polylysine (solubilized by reaction with citraconic anhydride), j. copolymers of lysine-phenylalanine, lysinetryrosine, and glutamic acid-tyrosine; CD represents a covalently bound cytotoxic drug selected from the group comprising: p-[N,N-bis(2-chloroethyl)]phenylenediamine, p-[bis(2-chloroethyl)amino]phenylalanine, 4-{p-[bis(2-chloroethyl)amino]phenyl}butyric acid, 2-amino-N-[p-bis(2-chloroethylamino]phenyl-3-hydroxypropionamide, 2-amino-N-[p-bis(2-chloroethyl)amine]phenyl-3-hydroxy-2-hydroxymethyl propionamide, N-{p{[(2,4-diamino-6-pteridinyl)methyl]methylamino}benzyl}-L-glutamic acid, cytosine arabinoside, cytosine arabinoside monophosphate, O-[n,n-bis(2-chloropropyl)]carbamoylglycollic acid, daunomycin, doxorubicin, and diphtheria toxin; B 1 represents a covalent bond between Ig and polymer carrier of the formula ##STR44## B 2 represents a covalent bond between the polymer carrier and CD of the formula ##STR45## m = 5-500; n = 1-10.
Claim 4
Dependent Claim 55 words
A cytotoxic agent according to claim 2 wherein the polymer carrier is dextran, molecular weight 5000-500,000, activated with cyanogen bromide to form cycloimidocarbonate and functionalized with 1,6-diaminohexane; CD represents covalently bound p-[N,N-bis(2-chloroethyl)]phenylenediamine, p-[bis(2-chloroethyl)amino]phenyl-3-hydroxypropionamide, or 2-amino-N-[p-bis(2-chloroethyl)amino]phenyl-3-hydroxy-2-hydroxymethyl propianamide; B 1 represents -- N═CH--(CH 2 ) 3 --CH═N--; B 2 represents ##STR46## m = 5-500; n = 1-10.
Claim 5
Dependent Claim 15 words
A cytotoxic agent according to claim 3 wherein the dextran has a molecular weight 5,000-50,000.
Claim 6
Dependent Claim 17 words
A cytotoxic agent according to claim 13 wherein the dextran has a molecular weight of about 17,000.
Claim 7
Dependent Claim 42 words
A cytotoxic agent according to claim 2 wherein the polymer carrier is polyglutamic acid, molecular weight 5000-500,000; CD represents covalently bound p-[N,N-bis(2-chloroethyl)]phenylenediamine, p-[bis(2-chloroethyl)amino]phenylalanine, 2-amino-N-[p-bis(2-chloroethyl)amino]phenyl-3-hydroxypropionamide, or 2-amino-N-[p-bis(2-chloroethyl)amino]phenyl-3-hydroxy-2-hydroxymethyl propionamide; B 1 represents ##STR47## B 2 represents ##STR48## m = 5-500; and n = 1-10.
Claim 8
Dependent Claim 17 words
A cytotoxic agent according to claim 6 wherein the polyglutamic acid has a molecular weight of 5,000-100,000.
Claim 9
Dependent Claim 18 words
A cytotoxic agent according to claim 6 wherein the polyglutamic acid has a molecular weight of about 35,000.
Claim 10
Dependent Claim 55 words
A cytotoxic agent according to claim 2 wherein the polymer carrier is polylysine solubilized by reaction with citraconic anhydride and having a molecular weight of 5,000-100,000; Cd represents p-[bis(2-chloroethyl)amino[phenylalanine, 4-{p-[bis(2-chloroethyl)amino]phenyl}butyric acid, or N-{p{[2,4-diamino-6-pteridinyl)methyl]methylamino}benzyl}-L-glutamic acid; B 1 is ##STR49## or --N═CH--(CH 2 ) 3 --CH═N--; B 2 is ##STR50## m = 5-500 and n = 1-10.
Claim 11
Dependent Claim 48 words
A cytotoxic agent according to claim 2 wherein the polymer carrier is polyethyleneimine having a molecular weight of 5,000-500,000; Cd represents p-[bis(2-chloroethyl)amino]phenylalanine, 4-{p-[bis(2-chloroethyl)amino]phenyl}butyric acid or N-{p{[2,4-diamino-6-pteridinyl)methyl]methylamino}benzyl}-L-glutamic acid; B 1 is ##STR51## or --N═CH--(CH 2 ) 3 --CH═N--; B 2 is ##STR52## m = 5-500 and n = 1-10.
Claim 12
Dependent Claim 19 words
A cytotoxic agent according to claim 10 wherein the polymer carrier is polyethyleneimine having a molecular weight of 5,000-100,000.
Claim 13
Dependent Claim 18 words
A cytotoxic agent according to claim 10 wherein the polymer carrier has a molecular weight of about 20,000.
Claim 14
Dependent Claim 48 words
A cytotoxic agent according to claim 1 represented by the formula ##STR53## wherein the polymer carrier is polyglutamic acid of molecular weight 5000-500,000; Cd represents covalently bound p-[N,N-bis(2-chloroethyl)]phenylenediamine, p-[bis(2-chloroethyl)amino]phenylalanine, 2-amino-N-[p-bis(2-chloroethyl)amino]phenyl-3-hydroxypropionamide, or 2-amino-N-[p-bis(2-chloroethyl)amino]phenyl-3-hydroxy-2-hydroxymethyl propionamide; B 1 represents ##STR54## B 2 represents ##STR55## m = 5-500; and n = 1-10.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-09-05 1981-03-07 1981-09-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-09-05 1985-03-07 1985-09-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-09-05 1989-03-07 1989-09-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag